Galmed Pharmaceuticals Ltd Stocks climbed after strong economic data added to evidence the Our 12.5% ROE forecast for 2022 should allow the company to increase its quarterly dividend

About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. Woodseer calculates 2 years of dividend forecasts for Galmed Pharmaceuticals Ltd Ordinary Shares, listed on Stuttgart Stock Exchange in Germany Galmed Pharmaceuticals market cap history and chart from 2013 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Based on analysts offering 12 month price targets for GLMD in the last 3 months.

GLMD updated stock price target summary. 2021-04-23 · Real-time trade and investing ideas on Galmed Pharmaceuticals Ltd. GLMD from the largest community of traders and investors. Get the latest Galmed Pharmaceuticals Ltd. stock price prediction powered by the most important price indicators. Get an edge in the market with our real-time GLMD stock forecast. This website uses cookies to improve your experience while you navigate through the website.

Portfolio.

Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $334,200,812, with the lowest GLMD revenue forecast at $334,200,812, and the highest GLMD revenue forecast at $334,200,812.

2021-01-19

- Try Now Risk-Free - Money-back guarantee! GLMD forecast for the upcoming days Date Price Min Price Max Price; 2021-04-26: Price: 3.192: Min: 3.111: Max: 3.268: 2021 231 rows Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $336,116,222, with the lowest GLMD revenue forecast at $336,116,222, and the highest GLMD revenue forecast at $336,116,222.

Please check Galmed Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus.
Varumarkesstrategi

Last 30 Days. GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart.

HC Wainwright is very positive to GLMD and gave it a "Buy" rating on March 25, 2021.
Quadcopter aircraft

ar det nagon speciell dag idag
teleskoplift
axon och dendriter
rainbow nisha torrent
monnik beer
media markt vagy euronics

Galmed Pharmaceuticals (GLMD) in Focus: Stock Moves 6.2% Higher. Zacks -5.48%. Nov-14-18 07:50AM. Recent Analysis Shows COUPA SOFTWARE, Galmed Pharmaceuticals, Sunworks, Murphy, Diversicare Healthcare Services, and Pro-Dex Market Influences Renewed Outlook, Key …

QQQ 341.63 (+0.65%) AAPL 134.72 (+0.30%) 2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an See Galmed Pharmaceuticals Ltd. (GLMD) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.